Results 21 to 30 of about 100,956 (280)
Molecular Therapy: Oncolytics, 2016 To target oncolytic measles viruses (MV) to tumors, we exploit the binding specificity of designed ankyrin repeat proteins (DARPins). These DARPin-MVs have high tumor selectivity while maintaining excellent oncolytic potency.
Jan RH Hanauer +15 more
doaj +1 more source
Molecular Therapy: Oncolytics, 2019 Measles virus (MeV) is naturally cytolytic by extensive cell-to-cell fusion. Vaccine-derived MeV is toxic for cancer cells and is clinically tested as oncolytic virus.
Jan R.H. Hanauer +3 more
doaj +1 more source
Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. [PDF]
PLoS ONE, 2017 The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live ...
Fan-Ya Meng +7 more
doaj +1 more source
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from Nigeria. [PDF]
Hum Vaccin ImmunotherNigeria has the highest burden of measles worldwide, as measles vaccine uptake remains low. Recently, the second dose of the measles-containing vaccine (MCV2) was introduced as part of the routine immunization (RI) program, and this study examined how it
Sato R.
europepmc +2 more sources
Human Vaccines & Immunotherapeutics, 2022 Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama +11 more
doaj +1 more source
EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS
Медицинская иммунология, 2014 . The review article considers different variants of measles vaccine that may be classified into two groups, i.e., vaccines that do not contain viable measles virus, and attenuated measles vaccines which could be employed in unusual manner.The first ...
V. A. Liashenko
doaj +1 more source
Predictors for low coverage of uptake of second dose of measles vaccine among children in sub-Saharan Africa, 2023: a systematic review and meta-analysis. [PDF]
J Pharm Policy PractBackground Measles became a public health important disease in sub-Saharan Africa. World Health Organization recommended measles-containing vaccine dose 2 (MCV2) through routine service delivery.
Melis T +5 more
europepmc +2 more sources
Measles vaccination of special risk groups
Human Vaccines & Immunotherapeutics, 2021 Measles is an important vaccine preventable disease with significant morbidity and mortality. Although measles vaccine is a safe and effective vaccine available worldwide for more than 50 years, still immunization efforts have not successfully reached ...
Vassiliki Papaevangelou
doaj +1 more source
Laboratory diagnosis of vaccine-associated measles in Zhejiang Province, China
Journal of Microbiology, Immunology and Infection, 2017 Background/Purpose: Along with the improving vaccine coverage, suspected vaccine-associated measles has been reported in Zhejiang Province, China. In order to maintain the accuracy of the measles surveillance system, it is critical to discriminate ...
Chang-Ping Xu +4 more
doaj +1 more source
The Hajj 2019 Vaccine Requirements and Possible New Challenges [PDF]
, 2019 Each year millions of pilgrims perform the annual Hajj from more than 180 countries around the world. This is one of the largest mass gathering events and may result in the occurrence and spread of infectious diseases.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core +1 more source